Twice weekly tuberculosis chemotherapy.
D000041:Absenteeism; D000284:Administration, Oral; D000328:Adult; D000368:Aged; D003120:Colorado; D003153:Community Health Services; D004977:Ethambutol / Q000627:therapeutic use; D005069:Evaluation Studies as Topic; D005260:Female; D005500:Follow-Up Studies; D006760:Hospitalization; D006801:Humans; D007273:Injections, Intramuscular; D007538:Isoniazid / Q000008:administration & dosage* / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D011736:Pyridoxine / Q000627:therapeutic use; D013307:Streptomycin / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use; D014376:Tuberculosis / Q000188:drug therapy*; D014756:Viomycin / Q000627:therapeutic use
D004977:Ethambutol; D011736:Pyridoxine; D007538:Isoniazid; D013307:Streptomycin; D014756:Viomycin